Biosite Diagnostics Launches Coronary Collaboration

Biosite Diagnostics Incorporated has announced the launch of a collaborative Biosite Discovery program to identify novel proteins that can advance care for patients with acute coronary syndrome, or ischemic heart disease, the most common cause of death worldwide. The collaboration leverages Biosite’s existing partnership with Large Scale Proteomics Corporation and introduces new clinical collaborators, including Read more about Biosite Diagnostics Launches Coronary Collaboration[…]

AME Signs Licensing Agreement With IDEXX For Diagnostic Development

Applied Molecular Evolution, Inc., has granted a non-exclusive sublicense to IDEXX Laboratories, Inc., for Applied Molecular Evolution’s (AME’s) Kauffman patents for directed evolution. IDEXX plans to use the Kauffman patents to develop diagnostic applications. “We believe that IDEXX’ decision to take this license reflects the value of our proprietary position in the field of directed Read more about AME Signs Licensing Agreement With IDEXX For Diagnostic Development[…]

Diagnostic Products And Minerva Sign Development Agreement

Diagnostic Products Corp. and Minerva Pharmaceuticals Inc. have entered into a license agreement for the development of immunoassays for a newly described malignancy protein. Minerva Pharmaceuticals is a privately held Baltimore-based company formed for the purpose of commercialising platform technology licensed from the University of Maryland. Minerva founding scientists discovered that altered components of the Read more about Diagnostic Products And Minerva Sign Development Agreement[…]

Inspire And Kirin Enter Diagnostics Collaboration

Inspire Pharmaceuticals, Inc. announced a licensing agreement with Kirin Brewery Co., Ltd., of Tokyo, Japan, in which Kirin’s Pharmaceutical Division has obtained rights to develop and commercialise Inspire’s lung-disease diagnostic adjunct product, INS316 Diagnostic, in twenty- one Asian countries and regions including Japan. The initial indication for INS316 will be to aid in the diagnosis Read more about Inspire And Kirin Enter Diagnostics Collaboration[…]

Applied Imaging And Rigshospitalet University Agree Collaboration

Applied Imaging Corp. has teamed with Drs. Hans Skovgaard Poulsen and Jens Benn Sorensen from the Department of Oncology at the Rigshospitalet University of Copenhagen, Denmark, to optimize and validate a new blood test for the early diagnosis of cancer metastasis. The initial study will focus on patients suffering from colorectal tumors of all stages Read more about Applied Imaging And Rigshospitalet University Agree Collaboration[…]

ImClone And DAKO To Develop Screening Kit

ImClone Systems Incorporated and DAKO Corporation have entered into an agreement for the development of an Epidermal Growth Factor receptor (EGFr) screening kit. EGFr is a receptor associated with tumor cell growth in a number of solid tumors. The kit, to be developed by DAKO, will screen patients’ tumors for over-expression of EGFr as a Read more about ImClone And DAKO To Develop Screening Kit[…]

Chiron Patent For HCV Nucleic Acid Testing Upheld

Chiron Corporation has announced that the European Patent Office Technical Board of Appeals upheld the validity of Chiron’s European HCV Patent No. 0 318 216 in amended form. The final ‘216 patent contains broad claims that cover nucleic acid testing (NAT) for hepatitis C virus (HCV) detection and the manufacture, use or sale of such Read more about Chiron Patent For HCV Nucleic Acid Testing Upheld[…]

Large Scale Proteomics And Biosite Diagnostics Agree Collaboration

Large Scale Proteomics Corporation and Biosite Diagnostics, Incorporated have agreed a strategic discovery collaboration in the development of next-generation diagnostics. In the collaboration LSPC will apply its proprietary proteomic discovery technologies to identify novel targets from patient samples provided by Biosite Discovery, Biosite’s program aimed at the discovery of new markers of disease. Under the Read more about Large Scale Proteomics And Biosite Diagnostics Agree Collaboration[…]

Berlex Licenses DoubleTwist Clustering And Alignment Tools

DoubleTwist, Inc. has announced that Berlex Laboratories, Inc. has licensed DoubleTwist’s proprietary Clustering and Alignment Tools. As DoubleTwist’s best-selling product, the computational tools enable companies to quickly cluster and align high volumes of expressed sequence tags (ESTs) and genomic sequences into full-length gene sequences suitable for gene indexing and other applications in drug discovery. “We Read more about Berlex Licenses DoubleTwist Clustering And Alignment Tools[…]

Combimatrix Achieves Milestone In Strategic Alliance With Toppan

Acacia Research Corporation announced its CombiMatrix Group has achieved a milestone in its multi-year strategic alliance with Toppan, resulting in a $1,250,000 payment. CombiMatrix received an initial $1 million upfront payment in May of this year from Toppan when the alliance was formed. Amit Kumar, Ph.D., President and Chief Executive Officer of CombiMatrix, commented, “We Read more about Combimatrix Achieves Milestone In Strategic Alliance With Toppan[…]